ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 1323 • ACR Convergence 2024

    Drug Abuse Screening in Patients Who Fulfill the 2016 Fibromyalgia Criteria

    Laura Aline Martinez-Martinez1, Angelica Beltran-Barajas2, Mayra Nadia Quintanar-Cuevas3, David Vera Bustamante4, Itzel Palafox Sosa5, Karyme Zazil Velazquez-Zarza6, Salvador Zuñiga-Roman6 and Luz Angelica Viruel-Mejia7, 1Rheumatology Department - National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 2Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, 3Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, México, Mexico, 4Benemerita Universidad Autonoma de Puebla, Heroica Puebla de Zaragoza, Puebla, Mexico, 5Escuela Superior de Medicina-Instituto Politecnico Nacional, Ciudad de México, Mexico, 6Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 7Rheumatology Departement at National Institute of Cardiology Ignacio Chavez - Universidad Autonoma del Estado de Hidalgo, Tula de Allende, Hidalgo, Mexico

    Background/Purpose: The clinical association of fibromyalgia with symptoms of anxiety and depression is well recognized [Uçar M, et al. J Int Med Res 2015;43(5):679-85]. Emotional…
  • Abstract Number: 0124 • ACR Convergence 2024

    Sexual Health Challenges in Primary Antiphospholipid Syndrome: Exploring Prevalence and Clinical Correlates

    Jonathan Campos-Guzmán1, María Espinosa-León2, Iris Paola García Herrera1, Iris Jazmín Colunga Pedraza3, Mariel Martínez-Ruiz1, Ana Barrera-Vargas4, Guillermo Guaracha Basañez5 and javier Merayo Chalico6, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Federal District, Mexico, 5Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirón", Mexico City, Mexico, 6Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, CDMX, Mexico

    Background/Purpose: Antiphospholipid syndrome (APS) is a systemic thromboinflammatory disease with various forms of presentation. There is limited information on sexual function in patients with APS,…
  • Abstract Number: 1676 • ACR Convergence 2024

    Changing Patients’ Mindsets About Non-Severe Side Effects of Methotrexate: A Randomized Controlled Trial

    Rachael Yielder1, Kari Leibowitz2, Alia Crum2, Paul Manley3, Nicola Dalbeth1 and Keith Petrie4, 1University of Auckland, Auckland, New Zealand, 2Stanford University, Palo Alto, CA, 3Te Whatu Ora Health New Zealand, Auckland, New Zealand, 4The University of Auckland, Auckland, New Zealand

    Background/Purpose: Although methotrexate (MTX) is a first-line treatment for inflammatory rheumatic diseases, side effects can lead to poor adherence and persistence. A novel intervention involves…
  • Abstract Number: 0165 • ACR Convergence 2024

    Exploring Changes in Daily Behaviors with Changes in Physical Function over 24 Weeks in Adults with Knee OA

    Thomas Videtich Bye1, Isabella Granetzke1, Sydney Liles2, Jennifer Copson3, Laura Schmitt1, Jason Jakiela4 and Daniel White1, 1University of Delaware, Newark, DE, 2University of Delaware, Elkton, MD, 3University of Delaware, Wilmington, DE, 4Winston-Salem State University, Winston-Salem, NC

    Background/Purpose: Knee osteoarthritis (OA) is a common cause of pain that often leads to limitations in physical function, e.g., difficulty walking or climbing stairs, in…
  • Abstract Number: 1723 • ACR Convergence 2024

    Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm

    Fabio Cacciapaglia1, Vincenzo Venerito2, Gian Luca Erre3, Matteo Piga4, Andreina Manfredi5, Garifallia Sakellariou6, Ombretta Viapiana7, Elisa Gremese8, Elena Bartoloni Bocci9, Francesca Romana Spinelli10 and Fabiola Atzeni11, and "Cardiovascular Obesity and Rheumatic DISeases" Study Group of the Italian Society of Rheumatology, 1Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Rheumatology Unit, DiMePRe-J University of Bari, Bari, Italy, 3Rheumatology Unit - University of Sassari, Sassari, Italy, 4Rheumatology Unit - University of Cagliari, Cagliari, Italy, 5University of Modena and Reggio Emilia, Modena, 6Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 7Rheumatology Unit, University of Verona, Verona, Italy, 8Catholic University of the Sacred Heart, Rome, Rome, Italy, 9Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 10Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 11University of Messina, Italy, Messina, Italy

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased cardiovascular (CV) risk, but traditional CV risk factors and available 10-year CV risk estimation models may not…
  • Abstract Number: 0273 • ACR Convergence 2024

    Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study

    Elizabeth Lopez1, Lesley Jackson2, Kenneth Saag3 and Maria I. ("Maio") Danila4, 1University of Alabama at Birmingham, Montgomery, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3The University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: Many people with gout utilize the emergency department (ED) for acute gout care, but many do not receive subsequent adequate outpatient care for long-term…
  • Abstract Number: 1913 • ACR Convergence 2024

    Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

    Mrinalini Dey1, Shyam Budhathoki2, Sofia Ramiro3, Kaleb Michaud4, Helen Elwell5, Sam Norton6, Maya H. Buch7, Andrew Cope1, Richard Osborne8, James Galloway9 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2Imperial College London, London, United Kingdom, 3Leiden University Medical Center, Bunde, Netherlands, 4University of Nebraska Medical Center, Omaha, NE, 5British Medical Association, London, United Kingdom, 6King's College London, London, England, United Kingdom, 7Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 8Swinburne University of Technology, Swinburne, Australia, 9Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Health literacy (HL) is a key social determinant of health in inflammatory arthritis (IA), including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, as it…
  • Abstract Number: 0354 • ACR Convergence 2024

    Factors Associated with Health Information Technology Use Among United States Adults with Arthritis from 2012-2017: Analysis of the National Health Interview Survey

    Sarah Lieber1, Jerad Moxley2, M. Carrington Reid2 and Sara Czaja2, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY

    Background/Purpose: Health information technology (HIT) use has been associated with numerous benefits including improvements in quality of care and patient safety. Factors associated with HIT…
  • Abstract Number: 1929 • ACR Convergence 2024

    Use of Digital Health Tools for Health Promotion Among Individuals with Rheumatologic Diseases in the United States

    Ufuoma Mamoh1, Soziema Salia1, Alejandro Jaller1, Comfort anim-koranteng2, Joshua Halliday3, Joseph Atarere4, Ted Akhiwu1 and Indira Acharya1, 1Medstar Union Memorial Hospital, Baltimore, MD, 2Harlem Medical Center, Harlem, NY, 3Grreater Accra Regional Hospital, Accra, Ghana, 4Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, MD

    Background/Purpose: Rheumatologic diseases (RDs) significantly impact the quality of life, cause significant socioeconomic burdens, and increase the risk of other systemic diseases including cardiovascular disease,…
  • Abstract Number: 0365 • ACR Convergence 2024

    Patients’ Behaviors and Beliefs Around Dietary Changes Among a Cohort of Patients with Rheumatic Disease

    Aaron Stubbs, Deeba Minhas, Anne Arewasikporn and Andrew Schrepf, University of Michigan, Ann Arbor, MI

    Background/Purpose: Dietary interventions may help manage inflammation and are considered for adjunctive treatment of rheumatic diseases.  Our study aimed to explore patients' behaviors and beliefs…
  • Abstract Number: 2014 • ACR Convergence 2024

    Effect of a Whole Food Plant-Based Diet in Patients with Gout: A Pilot Randomized Controlled Trial

    Anna Kretova1, Carlijn Wagenaar1, Wendy Walrabenstein2, Daisy Vedder2, Dirkjan van Schaardenburg2 and Martijn Gerritsen1, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Amsterdam UMC, Amsterdam, Netherlands

    Background/Purpose: An unhealthy diet is an important modifiable risk factor for hyperuricemia and gout and is also associated with obesity and metabolic syndrome (MetS), known…
  • Abstract Number: 0366 • ACR Convergence 2024

    Factors Associated with Participation in Rheumatology Clinical Trials: A UK-based Study

    Koushan Kouranloo1 and Chris Wincup2, 1Internal Medicine Resident., London, United Kingdom, 2King's College Hospital, London, United Kingdom

    Background/Purpose: Clinicians are encouraged to consider patient preferences for offering face-to-face vs virtual consultations. This adaptability is particularly important to rheumatologists caring for patients with…
  • Abstract Number: 2159 • ACR Convergence 2024

    Reaching Those in Need: Understanding the Reach of a Digital Program for Lupus Self-Management Education

    Katherine Carpenter1, Melissa French2, Sara Johnson3, Janet Johnson3, Ashley Holden4, Joy Buie1, Melicent Miller1 and Mary Crimmings1, 1Lupus Foundation of America, Washington, DC, 2Lupus Foundation of America, Alexandria, VA, 3ProChange Behavior Solutions, South Kingstown, RI, 4Lupus Foundation of America, Bossier City, LA

    Background/Purpose: As part of a 5-year cooperative agreement with the Centers for Disease Control and Prevention, The Lupus Foundation of America (LFA) has implemented the…
  • Abstract Number: 0431 • ACR Convergence 2024

    Reproductive Health in Women with Rheumatic Diseases: Knowledge and Behaviors

    Abraham Yair Lujano-Negrete1, Lorena Perez-Barbosa2, Conrado Garcia3, CASSANDRA SKINNER TAYLOR4, Jose Hernandez Linas3, Adriana Lobato-Belmonte3, Yesenia Ambriz Murillo5, Alfonso Gastelum-Strozzi6, Amaranta Manrique de Lara7, Ana Rodriguez-Flores8, Jesus Cardenas-de la Garza9, Marco Maradiaga-Cecena10, Galilea Rodriguez Orozco11, Anahí Carrazco Chapa11, Dionicio Galarza-Delgado12 and Ingris del Pilar Pelaez Ballestas3, and Grupo de estudio de salud reproductiva en enfermedades reumáticas autoinmunes en Mexico, 1Hospital Universitario Jose Eleuterio Gonzalez, UANL, Internal Medicine, Monterrey, Mexico, Monterrey, Mexico, 2Hospital Universitario, UANL, Monterrey, Mexico, 3Hospital General de Mexico Dr. Eduardo Liceaga, Rheumatology, Mexico City, Mexico, Mexico, Mexico, 4HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 5Hospital Regional de Morelia, Rheumatology, Morelia, Mexico, Morelia, Mexico, 6Instituto de Ciencias Aplicadas y Tecnología, UNAM, Mexico City, Mexico, Monterrey, Mexico, 7Hospital General de Mexico Dr. Eduardo Liceaga, Rheumatology, Mexico City, Mexico, Mexico City, Mexico, 8Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 9Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 10Hospital General de Culiacan, Rheumatology, Culiacan, Mexico, Culiacan, Sinaloa, Mexico, 11Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 12UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARDs) affect women during their childbearing years, often leading to pregnancy complications. Effective management of this population requires family planning and…
  • Abstract Number: 2165 • ACR Convergence 2024

    Fertility Concerns in Adolescents and Young Adults Receiving Gonadotoxic Medications for Rheumatic Disease

    SHAHD FARAJALLAH1, Katie Dunnock2, Qing Yu3, Sangeeta Sule4 and Tova Ronis4, 1Children's national hospital, Washington DC, 2George Washington University, washington dc, 3George Washington University, washington dc, DC, 4Children's National Hospital, Washington, DC

    Background/Purpose: Adolescents and young adults diagnosed with rheumatic diseases often require treatment with teratogenic and cytotoxic medications to effectively manage their conditions. While these therapies…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology